Clinical Trial Update: Individualized Infiximab Dosing-Proof of Concept Study

View source ↗

Summary

A clinical trial update for a proof-of-concept study on individualized dosing of infliximab in inflammatory bowel diseases. The sponsor is Cedars-Sinai Medical …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Inflammatory Bowel Diseases | Status: UNKNOWN